ElectroCore Inc (ECOR)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$9.210.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · ECOR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 37.0 | 32.0 | 25.2 | 16.0 | 8.6 | 5.5 | 3.5 | 2.4 | 1.0 |
| Cost of Revenues | 4.8 | 4.2 | 3.8 | 2.8 | 1.6 | 1.4 | 1.7 | 1.2 | 0.6 |
| Gross Profit | 32.2 | 27.8 | 21.4 | 13.2 | 7.0 | 4.1 | 1.8 | 1.2 | 0.4 |
| Operating Expenses & Income | |||||||||
| Selling, General & Admin | 43.0 | 38.2 | 31.2 | 27.2 | 24.3 | 21.6 | 21.8 | 35.4 | 42.5 |
| R&D Expenses | — | — | 2.4 | 5.3 | 5.5 | 2.5 | 4.2 | 9.9 | 12.5 |
| Operating Income | (13.9) | (13.2) | (12.2) | (19.3) | (22.9) | (20.0) | (24.7) | (46.1) | (54.6) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | 0.8 | 0.6 | — | — | 0.0 | — | — | — | 6.3 |
| Other Non-Operating Income / Expenses | — | — | 0.2 | 0.2 | 0.3 | 2.0 | 0.1 | 1.0 | (1.2) |
| EBT, Incl. Unusual Items | (15.0) | (14.0) | (12.0) | (19.0) | (22.6) | (18.1) | (24.7) | (45.1) | (55.8) |
| Income Tax Expense | — | 0.0 | (0.1) | (0.2) | (0.4) | (0.9) | (1.2) | 0.0 | 0.0 |
| Net Income | |||||||||
| Minority Interest | — | — | — | — | — | — | — | 0.1 | 0.1 |
| Net Income | (14.8) | (14.0) | (11.9) | (18.8) | (22.2) | (17.2) | (23.5) | (45.1) | (55.8) |
| Per Share | |||||||||
| Basic EPS | (1,570.61) | (1.65) | (1.59) | (3.42) | (4.69) | (4.36) | — | — | — |
| Diluted EPS | (1,570.61) | (1.65) | (1.59) | (3.42) | (4.69) | (4.36) | — | — | — |
| Revenue per Share | 3,930.88 | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 0.0 | 0.0 | 7.5 | 5.5 | 0.0 | 0.0 | — | — | — |
| Diluted Weighted Avg Shares | 0.0 | 0.0 | 7.5 | 5.5 | 0.0 | 0.0 | — | — | — |
| Supplemental | |||||||||
| EBITDA | — | (12.7) | (11.4) | (18.3) | (22.3) | (19.7) | (24.3) | (45.8) | (54.5) |
| EBIT | (13.9) | (13.2) | (12.2) | (19.3) | (22.9) | (20.0) | (24.7) | (46.1) | (54.6) |
| Effective Tax Rate | — | — | — | 1.0% | 1.9% | 4.7% | 4.7% | -0.0% | -0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.